The case for combination antiviral therapy for chronic hepatitis B virus infection.
about
Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach.Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.A new polymorphism in the GRP78 is not associated with HBV invasion.
P2860
The case for combination antiviral therapy for chronic hepatitis B virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@en
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@nl
type
label
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@en
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@nl
prefLabel
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@en
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@nl
P1476
The case for combination antiviral therapy for chronic hepatitis B virus infection.
@en
P2093
Graeme J M Alexander
Kathryn L Nash
P304
P356
10.1016/S1473-3099(08)70102-6
P577
2008-05-14T00:00:00Z